Search
Novartis Healthcare

NOVARTIS PHARMA STEIN AG

Featured products of Novartis Pharma Stein
Lucentis
Lucentis soln for inj 10 mg/mL
ranibizumab
Packing/Price
(+ syringe) 2 mL x 1's (P24,426.00/box)
MIMS Class
Other Eye Preparations
ATC Classification
S01LA04 - ranibizumab : Belongs to the class antineovasculatisation agents. Used in the management of neovascular macular degeneration.
Pivikto
Pivikto FC tab 150 mg + 150 mg (300 mg daily dose)
alpelisib
Packing/Price
(14-day supply) 28's
MIMS Class
Targeted Cancer Therapy
ATC Classification
L01EM03 - alpelisib : Belongs to the class of phosphatidylinositol-3-kinase (Pi3K) inhibitors. Used in the treatment of cancer.
Pivikto FC tab 200 mg
alpelisib
Packing/Price
(14-day supply) 14's
MIMS Class
Targeted Cancer Therapy
ATC Classification
L01EM03 - alpelisib : Belongs to the class of phosphatidylinositol-3-kinase (Pi3K) inhibitors. Used in the treatment of cancer.
Pivikto FC tab 200 mg + 50 mg (250 mg daily dose)
alpelisib
Packing/Price
(14-day supply) 56's
MIMS Class
Targeted Cancer Therapy
ATC Classification
L01EM03 - alpelisib : Belongs to the class of phosphatidylinositol-3-kinase (Pi3K) inhibitors. Used in the treatment of cancer.
Scapho
Scapho powd for soln for inj 150 mg
secukinumab
Packing/Price
6 mL x 1's
MIMS Class
Disease-Modifying Anti-Rheumatic Drugs (DMARDs), Immunosuppressants, Psoriasis, Seborrhea & Ichthyosis Preparations
ATC Classification
L04AC10 - secukinumab : Belongs to the class of interleukin inhibitors. Used as immunosuppressants.
Scapho soln for inj
secukinumab
Packing/Price
1 mL x 1's
MIMS Class
Disease-Modifying Anti-Rheumatic Drugs (DMARDs), Immunosuppressants, Psoriasis, Seborrhea & Ichthyosis Preparations
ATC Classification
L04AC10 - secukinumab : Belongs to the class of interleukin inhibitors. Used as immunosuppressants.
Vsiqq
Vsiqq soln for inj 120 mg/mL
brolucizumab
Packing/Price
(single use, type 1 colourless glass w/ grey rubber stopper and aluminum seal w/ violet flip-off cap + 1 filter needle in soft blister) 2 mL x 1's
MIMS Class
Other Eye Preparations
ATC Classification
S01LA06 - brolucizumab : Belongs to the class antineovasculatisation agents. Used in the management of neovascular macular degeneration.
Distributed by Novartis Healthcare
Lucentis
Lucentis soln for inj 10 mg/mL
ranibizumab
Packing/Price
(+ syringe) 2 mL x 1's (P24,426.00/box)
MIMS Class
Other Eye Preparations
ATC Classification
S01LA04 - ranibizumab : Belongs to the class antineovasculatisation agents. Used in the management of neovascular macular degeneration.
Pivikto
Pivikto FC tab 150 mg + 150 mg (300 mg daily dose)
alpelisib
Packing/Price
(14-day supply) 28's
MIMS Class
Targeted Cancer Therapy
ATC Classification
L01EM03 - alpelisib : Belongs to the class of phosphatidylinositol-3-kinase (Pi3K) inhibitors. Used in the treatment of cancer.
Pivikto FC tab 200 mg
alpelisib
Packing/Price
(14-day supply) 14's
MIMS Class
Targeted Cancer Therapy
ATC Classification
L01EM03 - alpelisib : Belongs to the class of phosphatidylinositol-3-kinase (Pi3K) inhibitors. Used in the treatment of cancer.
Pivikto FC tab 200 mg + 50 mg (250 mg daily dose)
alpelisib
Packing/Price
(14-day supply) 56's
MIMS Class
Targeted Cancer Therapy
ATC Classification
L01EM03 - alpelisib : Belongs to the class of phosphatidylinositol-3-kinase (Pi3K) inhibitors. Used in the treatment of cancer.
Scapho
Scapho powd for soln for inj 150 mg
secukinumab
Packing/Price
6 mL x 1's
MIMS Class
Disease-Modifying Anti-Rheumatic Drugs (DMARDs), Immunosuppressants, Psoriasis, Seborrhea & Ichthyosis Preparations
ATC Classification
L04AC10 - secukinumab : Belongs to the class of interleukin inhibitors. Used as immunosuppressants.
Scapho soln for inj
secukinumab
Packing/Price
1 mL x 1's
MIMS Class
Disease-Modifying Anti-Rheumatic Drugs (DMARDs), Immunosuppressants, Psoriasis, Seborrhea & Ichthyosis Preparations
ATC Classification
L04AC10 - secukinumab : Belongs to the class of interleukin inhibitors. Used as immunosuppressants.
Vsiqq
Vsiqq soln for inj 120 mg/mL
brolucizumab
Packing/Price
(single use, type 1 colourless glass w/ grey rubber stopper and aluminum seal w/ violet flip-off cap + 1 filter needle in soft blister) 2 mL x 1's
MIMS Class
Other Eye Preparations
ATC Classification
S01LA06 - brolucizumab : Belongs to the class antineovasculatisation agents. Used in the management of neovascular macular degeneration.

Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Already a member? Sign in
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Already a member? Sign in